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Pulsed-field gel electrophoresis (PFGE) of Bordetella pertussis chromosomal DNA fragments generated by
XbaI restriction has been used to subtype isolates for epidemiologic studies. To better understand the natural
history of pertussis, we determined the PFGE profiles of 1,333 strains isolated in the United States from 1935
to 1999. Results showed a shift in prevalent profiles from the earliest to the latest study periods. In addition,
genetic diversity decreased over time, and prevalent profiles were more highly related to each other than to
less common profiles. These results provide the foundation for investigating the impact of prevention strate-
gies, including the use of the acellular vaccines, on the currently circulating B. pertussis population.
ertussis, or whooping cough, is an acute respiratory disease
caused by Bordetella pertussis. Before pertussis vaccine
was introduced in the United States in the mid-1940s, pertussis
was a major cause of childhood illness and infant death (1).
Pertussis incidence decreased after vaccination programs were
introduced, and cases were reduced >90% compared with the
prevaccination era. Despite vaccine intervention, pertussis
remains endemic and epidemic peaks recur every 3 to 5 years
(1-8). Since the early 1980s, the reported incidence of pertussis
has increased, especially among adolescents and young adults
(1,2,4). 
Because vaccination coverage has been continuously high
during this period, the observed shift in pertussis epidemiology
may be a consequence of pertussis diagnosis and reporting or
host factors, such as waning vaccine-induced immunity. A
third explanation involves changes in the circulating B. pertus-
sis population leading to increased virulence or resistance to
vaccine-induced immunity. Differences in B. pertussis genetic
subtypes circulating in the pre- and post-vaccination eras were
demonstrated in the Netherlands, but the role of vaccination in
subtype selection remains equivocal (9-11). Consequently,
documentation of the natural history of the U.S. B. pertussis
population may help explain recent and past changes in pertus-
sis epidemiology and provides the comparative basis for recog-
nizing current and future trends, including those potentially
associated with prevention strategies. 
Two principal technologies differentiate epidemiologically
relevant strains of B. pertussis: gene-sequencing analysis and
pulsed-field gel electrophoresis of genomic DNA fragments
generated by endonuclease restriction (PFGE). In general,
sequencing analysis applies to genes with specified relevance,
such as virulence determinants, while PFGE subtyping pro-
vides a broader perspective of the genome. PFGE subtyping
has produced stable and highly reproducible profiles of B. per-
tussis isolates in different laboratories and has sensitively dis-
criminated among epidemiologically distinct isolates (12-15).
Therefore, we used genetic subtyping of recently and previ-
ously circulating B. pertussis isolates to elucidate the natural
history of this pathogen in the United States from 1935 to 1999
and assessed subtypes for temporal trends.
Material and Methods
Bacterial Strains
A total of 1,333 B. pertussis strains were examined, includ-
ing a convenience sample of 16 strains from 1935 to 1965 (des-
ignated archival); 127 strains from 1966 to 1985 (designated
medial); and 1,190 strains from 1986 to 1999 (designated con-
temporary). Archival and medial isolates were from several
different collections. Many of the later contemporary isolates
were from enhanced surveillance programs. Overall, 61% of
the isolates were from the metropolitan Cincinnati area (n =
480), Massachusetts (n = 205), or Minnesota (n = 125). A sec-
ond analysis of PFGE profile results excluded the 480 Cincin-
nati isolates (1989 to 1996) and thus was based on 710
contemporary and 853 total strains. (A table listing all strains
and PFGE profiles is available upon request.) Profiles were
designated according to Centers for Disease Control and Pre-
vention nomenclature, whereby: CY = Bordetella; X = pertus-
sis; XI =  XbaI; and three number fields identify the PFGE
profile. Thus, CYXXI-010 identifies PFGE profile #10 derived
from XbaI restriction of B. pertussis genomic DNA. B. pertussis Centers for Disease Control and Prevention, Atlanta, Georgia, USA
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isolates were grown for 3 to 5 days at 37°C on charcoal agar
supplemented with 10% defibrinated horse blood under ambi-
ent air and high humidity.
Preparation of Chromosomal DNA
Chromosomal DNA was prepared by following the PFGE
protocol published by Gautom (16), with modifications. Cells
of each strain were harvested after 3 to 5 days’ incubation, and
suspended in 2 mL of Tris EDTA buffer. The optical density of
each cell suspension was adjusted between 0.48 and 0.52 by
using a MicroScan turbidity meter (Baxter Diagnostics Inc.,
Deerfield, IL). Two hundred microliters of each suspension
were transferred to 1.5-mL microcentrifuge tubes, and 10 µL
of a 20 mg/mL solution of proteinase K (Amresco, Solon, OH)
was added. Tubes were gently inverted six times, and 200 µL
of the previously described 1.6% InCert agarose/SDS solution
was added. The cell and agarose suspensions were mixed with-
out aerosolizing by aspirating and expelling with a 200-µL
pipetter and were immediately dispensed into two wells of a
100-µL disposable plug mold (Bio-Rad Laboratories, Her-
cules, CA) and allowed to solidify at ambient temperature.
Plugs were transferred to 2-mL round-bottom microcentrifuge
tubes containing 1.5 mL of the previously described EDTA/
Sarcosine buffer and 40 µL of a 20-mg/mL solution of protein-
ase K. Tubes were immersed horizontally in a reciprocal shak-
ing water bath (130 strokes per minute) at 50°C and incubated
for 1.5 hours. The plugs were then transferred to 50-mL coni-
cal centrifuge tubes and washed with 10 mL of sterile distilled
water for 15 minutes, then five times in 10 mL of the previ-
ously described Tris EDTA buffer for 30 minutes each. For
each wash, tubes were placed in a reciprocal shaking water
bath at 50°C and 150 strokes per minute. Plugs were stored and
maintained in fresh plug wash buffer at 4°C for up to 4 months
before restriction endonuclease digestion. 
Restriction Endonuclease Digestion and PFGE
Two 1-mm slices of the prepared plugs were cut with a
sterile razor blade and transferred to 1.5-mL microcentrifuge
tubes containing 100 µL of XbaI digestion solution (30 U of
XbaI in the manufacturer’s supplied buffer; Roche Diagnostics,
Indianapolis, IN). Plug slices were incubated at 37°C for 1.5
hours. One plug slice of each strain and three slices of a phage
lambda molecular weight standard (PFGE Marker I; Roche
Diagnostics) were placed on the teeth of a 15-well comb and
allowed to adhere for 15 minute at ambient temperature. Mol-
ten 1% agarose in 0.5X Tris-Borate-EDTA buffer (TBE; Gibco
BRL, Rockville, MD), cooled to 50°C, was poured and
allowed to solidify around the comb. The comb was removed
and the resulting wells were filled with agarose. PFGE was
conducted in 0.5X TBE buffer in a contour-clamped homoge-
nous electric field apparatus (CHEF-Mapper or CHEF-DR III;
Bio-Rad). Electrophoresis was performed at 6V/cm for 18
hours at 14°C with a ramped switch time of 2.16 seconds to
35.07 seconds. Gels were stained for 25 minutes with gentle
rotation in 250 mL of deionized water containing 25 µL of a 10
mg/mL solution of ethidium bromide. Unbound ethidium bro-
mide was removed by washing gels in deionized water 3 times
for 30 minutes each. DNA fragments were visualized on a UV
transilluminator, and gels were photographed. The photo-
graphic negatives were scanned, and the DNA fragments were
analyzed with Diversity Database software (Bio-Rad) with at
least one band discrepancy as the basis for discriminating
among profiles. B. pertussis DNA fragment sizes were deter-
mined from their motilities relative to the phage lambda
molecular weight standard.
Statistical Analysis
We calculated genotypic diversity (GD) among profiles as
follows: GD=[n/(n-1)](1-Sxi
2 ), where xi is the frequency of
the ith PFGE profile and n is the total number of B. pertussis
strains. Values of GD range from 0 to 1, with “0” defined as a
population of isolates demonstrating identical profiles and “1”
representing a unique profile for each isolate. The statistical
significance of differences in GD values was evaluated by
computer simulation as described previously (11). A PFGE
profile relatedness diagram was constructed based on the
unweighted pair-group method with arithmetic mean
(UPGMA).
Results
We identified 105 PFGE profiles among the 1,333 B. per-
tussis isolates collected in the United States from 1935 to 1999
(Figure 1). We attempted to assess the geographic distributions
of identified profiles in the United States. However, the geo-
graphic distribution of archival and medial isolates was limited
by isolate collections available, which underrepresented cer-
tain regions. Thus, geographic trends in PFGE profile preva-
lences were not discernible. 
We also evaluated the temporal distribution of isolate pro-
files (Figures 1 and 2). Eleven, 35, and 17 profiles were
observed among 16 archival, 127 medial, and 1,190 contempo-
rary isolates, respectively. Specific profiles tended to be
restricted to isolates circulating during a given time period:
only 5 (CYXXI-014, -020,-064, -071, and -074) of the 11
archival isolate profiles were also detected in strains circulat-
ing in the medial period; and 15 (CYXXI-003, -004, -006,
-010, -014, -015, -017, -020, -021, -027, -053, -064, -066,
-074, and -114) of the 35 medial profiles were shared by con-
temporary isolates. Moreover, only four PFGE profiles
(CYXXI-014, -020, -064, and -074) were identified in 62 iso-
lates cultured in all three time intervals (Figure 2). Profiles
recovered from more than one time period tended to occur in
low frequency in later periods. We observed only 4 of 16 fre-
quencies >5% in a subsequent period: CYXXI-020 and
CYXXI-064 were seen in 8% and 9% of medial isolates,
respectively, and CYXXI-010 and CYXXI-027 were found in
37% and 6% of contemporary isolates, respectively. 
The most frequent profiles overall (CYXXI-010, -002,
-013, and -027) represented 33%, 10%, 9%, and 7%, of study
isolates, respectively (Table). However, the most frequent pro-46 Emerging Infectious Diseases  •  Vol. 8, No. 1, January 2002
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files in any given time period varied. The most frequent archi-
val profiles, CYXXI-014 (19%) and CYXXI-064 (19%),
collectively represented more than one third of the strains iso-
lated before 1966. As noted previously, the CYXXI-064 profile
continued into the medial period and was the third most preva-
lent profile after CYXXI-027 (13%) and CYXXI-062 (12%).
The three most prevalent contemporary PFGE profiles
(CYXXI-010, -002, and -013) represented approximately 58%
of the strains isolated since 1986. Profile CYXXI-082 emerged
in 1997 and has rapidly increased in frequency to account for
9% of the B. pertussis isolates from 1997 to 1999.
We evaluated the similarities between PFGE profiles of B.
pertussis isolates and recognized two major relatedness clus-
ters (clades) that were 58% similar (Figure 2). Seven additional
PFGE profiles were notable for their divergence (<50% simi-
lar). The three profiles (CYXXI-054, CYXXI-059, CYXXI-
060) representing the three earliest isolates from 1935 and
1939 were only 31% similar to Clades I and II. Interestingly,
contemporary isolates yielded the remaining four divergent
profiles (CYXXI-008, -033, -048, and -091). The eight nondi-
vergent profiles from the archival isolates formed a Clade I
subgroup with 68% similarity. PFGE profiles from the medial
isolates were unevenly distributed in both clades: 60% of
Clade I profiles and 16% of Clade II profiles represented 87%
and 13% of the medial isolates, respectively. The medial pro-
files in Clade I were more similar to each other (89% were
68% similar) than those in Clade II. Although contemporary
profiles were highly divergent, most (68%) resided in Clade II
and represented 78% of these isolates. 
A 62% similarity subgroup of Clade II profiles included the
three most frequent PFGE profiles during the contemporary
period and overall (CYXXI-002, -010, and -013). The most
frequent archival (CYXXI-014 and -064) and the most fre-
quent medial (CYXXI-027 and -062) profiles shared a 74%
similarity subgroup within Clade I. Two of these predominant
profiles (CYXXI-014 and -064) represented isolates from all
three time periods, as did profile CYXXI-020, which was also
in this relatedness subgroup. The fourth persistent profile,
CYXXI-074, was also in Clade I, but not within this 74% simi-
larity subgroup. 
The overall GD among the study isolates was 0.86. The GD
was 0.94 for the archival strains and 0.94 for the medial strains.
The GD decreased to 0.82 for contemporary strains. GD
among isolates from the period before vaccine intervention,
1935 to 1946, was 1.00 and decreased to 0.91 for the remainder
of the archival strains isolated from 1955 to 1965. Only the
decrease in GD between the medial (GD = 0.94) and contem-
porary (GD = 0.82) periods was significant (p<0.001).
We analyzed PFGE profile data, excluding the 480 contem-
porary isolates from Cincinnati (6), to evaluate how a large
source of isolates might affect our results (Table). With this
exclusion, 710 contemporary and 853 total isolates were tested.
Because 9 of 79 profiles representing contemporary isolates
were unique to Cincinnati (CYXXI-005, -008, -009, -022, -023,
-025, -030, -032, -035), a total of 96 PFGE profiles, including
70 from contemporary isolates, were included in the analysis.
Figure 1. Relatedness of pulsed-field gel electrophoresis profiles of Bor-
detella pertussis strains isolated in the United States,1935 to 1999.
Figure 2. Temporal distribution of 105 pulsed-field gel electrophoresis
profiles of Bordetella pertussis strains isolated in the United States,
1935 to 1999.Emerging Infectious Diseases  •  Vol. 8, No. 1, January 2002 47
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The prevalence of the predominant contemporary profile
CYXXI-010 did not change from approximately 33%. Con-
versely, the overall prevalencies of two other predominant pro-
files were affected, as CYXXI-002 prevalence decreased from
10% to 4% and CYXXI-013 increased from 9% to 14%.
Excluding Cincinnati isolates profiles, the total GD decreased
slightly from 0.86 to 0.84, as did the GD for the contemporary
isolates (1986 to 1999) from 0.82 to 0.79.
Discussion
There has been a resurgence of pertussis since the early
1980s in countries with high vaccination rates, including Aus-
tralia (17), Canada (14), Denmark (18), the Netherlands
(9,10,11,19), and the United States. Because this resurgence
may represent changes in the etiologic agent, we determined
the PFGE profiles of B. pertussis isolates circulating in the
United States between 1939 and 1999 and evaluated these
results for any trends with potential epidemiologic signifi-
cance. We recognized several major trends: different profiles
circulated and predominated at different times, the relatedness
among the PFGE profiles was consistent with a relatively
homogeneous population, the more frequent profiles were
more highly related to each other than to less common profiles,
and GD decreased over the study period.
The observed tendency of different profiles to circulate in
different periods was also reported from the Netherlands,
where 83% of DNA types were limited to single periods and
only one type was cultured in all successive periods (11).
Because PFGE profiles tended to be confined to a single time
period, different profiles predominated in different periods.
The two most predominant profiles (CYXXI-010 and -002) in
the contemporary period emerged in the mid-1980s, tempo-
rally dissociated with changes in intervention programs such as
vaccination, but coincident with an increasing incidence of
pertussis (4). A shift in the frequency of allelic types of two
immunogenic proteins, pertactin and pertussis toxin subunit A,
was also noted during this period, and the new allelic types
were strongly associated with isolates having the CYXXI-010
and -002 profiles (20). Additional study is needed to determine
the role of the newly predominant allelic types in conferring
predominance to these PFGE profiles, especially their distribu-
tion among less frequent profiles.
Our most dominant (33%) profile (CYXXI-010) is analo-
gous to Canadian profile (a), which represented 34% of all
Canadian isolates, suggesting that this profile is widely circu-
lating in North America. We also noted that PFGE profile
CYXXI-082 emerged in 1997 but still accounted for >2% of
the contemporary isolates, confirming the dynamic nature of
the population and suggesting that alternative profiles may pre-
dominant in the near future.
We determined PFGE profile similarities and evaluated
them for potential associations, especially with predominance
or persistence. No two of the 105 profiles were >93% similar,
and two major similarity groups, or clades, were identified.
The B. pertussis population studied in the Netherlands showed
similar organization (11). This relatedness structure most
likely represents the relatively homogeneous or clonal nature
of most pathogenic bordetellae, as previously suggested by
multilocus enzyme electrophoresis (21), DNA polymorphism
studies (22), and earlier characterizations of strains by PFGE
profiling (15,23). The distribution of several PFGE patterns
over all study periods and multiple locations is also consistent
with a homogeneous population. In general then, the observed
B. pertussis population structure likely represents adaptation to
a single host species and limited opportunity for horizontal
genetic exchange, although such exchange between B. pertus-
sis and B. parapertussis is evident (22,24).
The most prevalent profiles overall and in the median
period tended to be relatively highly related to each other, sug-
gesting that they may share common, but unknown, genetic
Table. Frequencies of the most prevalent pulsed-field gel
electrophoresis (PFGE) profiles of  Bordetella pertussis strains
isolated in the United States from 1935 to 1999
PFGE
Total 
US 
n=1,333
Total US 
w/o Cinn 
n=853
1935-
1965 
n=16
1966-
1985 
n=127
1986-
1999 
n=1,190
1986-1999 
w/o Cinn 
n=710
2 9.6 4.3 - - 10.8 5.4
3a 2.4 1.3 - 2.4 2.4 1.1
4a 3.7 0.4 - 0.8 4 0.3
6a 3.1 0.1 - 0.8 3.4 0.1
7 1.4 1.8 - - 1.6 2.1
8 2 - - - 2.2 -
10a 33.3 33.9 - 0.8 37.3 40.8
13 9.2 14.1 - - 10.3 17
14b 1.6 2.6 18.8 4.7 1.1 1.8
15a 2.6 0.8 - 1.6 2.7 0.8
17a 0.8 0.8 - 3.1 0.5 0.4
20b 1 1.5 6.3 8.7 0.2 0.1
21a 2.3 2.2 - 3.9 2.2 2
27a 7.1 9.3 - 13.4 6.5 8.8
37 0.7 1 - - 0.8 1.3
46 1.1 1.8 - - 1.3 2.2
52 0.4 0.6 - 3.9 - -
53a 0.3 0.5 - 1.6 0.2 -
62 1.1 1.8 - 11.8 - -
64b 1.4 2.2 18.8 9.4 0.3 0.6
66a 0.6 0.9 - 5.5 0.1 0.1
69 0.8 1.2 - 7.9 - -
71c 0.2 0.4 12.5 0.8 - -
74b 0.5 0.8 6.3 3.9 0.1 0.1
75 0.2 0.4 - 2.4 - -
82 2.1 3.3 - - 2.4 4
Total 89.5 88 62.7 87.4 90.4 89
aPFGE profile spans second and third time periods.
bPFGE profile spans all three time periods.
cPFGE profile spans first and second time periods.
CINN = Cincinnati, Ohio, data.48 Emerging Infectious Diseases  •  Vol. 8, No. 1, January 2002
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characteristics that confer dominance. The four persistent pro-
files that were observed in isolates from all time periods clus-
tered within Clade I with 68% similarity, suggesting that they
may share common properties for longitudinal transmission
and that these properties are different and unlinked from ele-
ments conferring highest prevalence. 
The similarity decreased between profiles from archival
and successive periods, and the most predominant profile in
the contemporary period showed the greatest divergence. In
particular, the PFGE profiles from the prevaccine era (before
1946) isolates were highly divergent from the postvaccination
isolate profiles. Others have proposed that the pre- versus post-
vaccination era population changes may have been driven by
selective pressure of whole-cell vaccines; the divergence in our
study is consistent with this proposal (9-11). However, the role
of vaccine selection in the divergence observed in our study
remains speculative because a relatively low number of iso-
lates was available from the archival period, GD did not
decrease significantly until the contemporary period, and simi-
larly divergent PFGE profiles were circulating in the contem-
porary period.
The divergence among profiles from contemporary isolates
was comparatively high, although the GD was lowest for this
period. A previous study indicated that increased recovery of
isolates led to detection of PFGE subtypes circulating at low
frequency (25). This suggests that the relatively large number
of contemporary isolates permitted identification of infrequent,
but divergent profiles not discernible in isolates from the other
two periods. Despite this observed divergence and the diversity
it implies, the frequency of predominant contemporary PFGE
subtypes was sufficiently high to depress the GD relative to the
previous periods. 
The GD (0.86) of the  B. pertussis population studied
resulted from the prevalence of only a few PFGE profiles,
combined with the low numbers of isolates represented by
most of the profiles. Investigations in Canada (14), the Nether-
lands (11), Italy (26), and Mexico (27) showed a similar ten-
dency: a few genomic profiles dominated and all others were
observed infrequently. Published GD values were also similar
in Dutch (11) and Mexican (27) studies, so our observations
may be characteristic for B. pertussis populations.
GD was consistent between the archival and the medial iso-
lates, but decreased significantly for the contemporary strains.
This reflects relatively fewer profiles representing a greater
proportion of contemporary isolates. In contrast, other investi-
gators found a significant decrease in GD in the period after
introduction of the whole-cell vaccine. Because the size of our
archival time period may have precluded our ability to distin-
guish a temporally relevant shift in GD, we also calculated GD
among isolates from early (1935 to 1955) and late (1956 to
1965) in this period. However, the change in GD was relatively
modest, from 1.00 to 0.93.
Evaluating the population structure of B. pertussis requires
sampling isolates representative of the natural distribution of
circulating strains. Three sampling artifacts were inherent in
our study. First, the numbers and geographic distribution of
archival and medial isolates were limited by the isolate collec-
tions available so that the number of contemporary isolates was
comparatively much greater. Second, most of the contempo-
rary isolates were from an enhanced surveillance project com-
prising only six sites (in Arizona, Georgia, Illinois,
Massachusetts, Minnesota, and New York). Consequently, the
restricted geographic distribution of available isolates pre-
cluded evaluating our results for relevant geographic trends.
However, the isolation of several prevalent profiles, such as
CYXXI-010, from multiple sites in the United States and Can-
ada was consistent with an essentially clonal population (21).
Third, an outbreak investigation such as occurred in Cin-
cinnati from 1991 to 1996 and Delaware in 1986 can contribute
a disproportionate number of isolates from a local area over a
short time because they are more likely to be recovered and
retained. To investigate the impact of this bias, we calculated
results with and without the Cincinnati PFGE profile data and
found that these results did change the prevalences of two of
the three predominant profiles, but not GD. Thus, regional dif-
ferences in profile frequencies apparently exist; future work
will attempt to confirm this. However, the impact of epidemic
strains did not seem to extend to the general population struc-
ture, as defined by GD. Epidemic isolates may limit PFGE pro-
file diversity, especially if clonal expansion had a major role in
causing the epidemic. However, we and others have shown that
this is not the usual case with pertussis epidemics in general
and in the Cincinnati epidemic in particular (11,14,24).
This study is the first to provide data about the distribution
of PFGE profiles among the U.S. B. pertussis population over
an extended period of time. Our results, together with pertussis
surveillance data, can serve as the comparative basis for evalu-
ating the potential impact of current and future prevention
strategies, including the use of acellular vaccines, on the circu-
lating B. pertussis population.
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